Dr Ian Campbell joins Action Against AMD Board of Trustees
Action Against AMD welcomes new trustee with executive management experience in the innovation, health, and life sciences sectors.
Action Against AMD is delighted to welcome a new trustee to support the exciting new stages of our development. Appointed in the last quarter of 2020, Dr Ian Campbell joins as an independent trustee bringing decades of experience acquired in executive and leadership roles within the innovation, life sciences, medical devices, and diagnostic sectors.
Dr Campbell is Chief Business Officer at LifeArc, a medical research charity. Ian was previously Executive Chair at Innovate UK, and before that Director for Health and Life Sciences. Prior to Innovate UK, Ian was Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay tests for cancers of the urogenital tract. A graduate of the University of Glasgow, Ian holds a PhD in Biochemistry.
Commenting on his appointment as an independent trustee, Ian said: 'I am impressed by the innovative approach Action Against AMD is taking to tackle the leading cause of vision loss in the UK and passionate about helping the team deliver their mission, ever more relevant as our population ages.'
Welcoming Ian's appointment, Rob Bryan, Chair of the AAAMD Board, remarked: ' Dr Ian Campbell's wealth of experience and invaluable insight will significantly complement our board. I am delighted that he will join us in overseeing the strategy, risk management, policies, operations, and performance of Action Against AMD. On behalf of the entire AAAMD Board and team, I would like to extend a very warm welcome to Ian.'
AAAMD CEO and Chief Scientist Dr Wen Hwa Lee added: 'I too am delighted to welcome Dr Ian Campbell to the AAAMD Board. Ian is a widely recognised leader in our sectors of activity and has described himself as a data-driven scientist that can repurpose his leadership skills to fit different organisations. We look forward to working with him over the coming years.'